Duke Early Phase Research Unit is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Duke Early Phase Research Unit has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Pulmonary Arterial Hypertension, Parkinson Disease, Alzheimer Disease.
Sponsors: Roham T. Zamanian, Intra-Cellular Therapies, Inc., Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Durham
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Early Phase Research Unit has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Early Phase Research Unit has 3 clinical trials on record, with 1 currently active. Their work covers Pulmonary Arterial Hypertension, Parkinson Disease, Alzheimer Disease.
Duke Early Phase Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.